These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 2951338)

  • 1. The distributional implications of using relative prices in DRG payment systems.
    Thorpe KE
    Inquiry; 1987; 24(1):85-95. PubMed ID: 2951338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of hospital case mix, cost, and payment differences for Medicare, Medicaid, and Blue Cross Plan patients using DRGs.
    Martin SG; Frick AP; Shwartz M
    Inquiry; 1984; 21(4):369-79. PubMed ID: 6240468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid and Blue Cross DRG payment plans: a comparison.
    Grimaldi PL
    Health Prog; 1985 Oct; 66(8):48-55, 79-80. PubMed ID: 10311310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is compression occurring in DRG prices?
    Lave JR
    Inquiry; 1985; 22(2):142-7. PubMed ID: 3159670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent evidence on case-based systems for setting hospital rates.
    Hellinger FJ
    Inquiry; 1985; 22(1):78-91. PubMed ID: 2933335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting the price right: Medicare payment rates for cardiovascular services.
    Hayes KJ; Pettengill J; Stensland J
    Health Aff (Millwood); 2007; 26(1):124-36. PubMed ID: 17211021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DRGs and hospital case records: implications for Medicare case mix accuracy.
    Johnson AN; Appel GL
    Inquiry; 1984; 21(2):128-34. PubMed ID: 6237993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the New Jersey all-payer DRG system.
    Rosko MD; Broyles RW
    Inquiry; 1986; 23(1):67-75. PubMed ID: 2937731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency, costs, and quality: the New Jersey experience revisited.
    Broyles RW
    Inquiry; 1990; 27(1):86-96. PubMed ID: 2139010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; changes to the hospital inpatient prospective payment system for acute care hospitals and fiscal year 2010 rates; and changes to the long-term care hospital prospective payment system and rate years 2010 and 2009 rates. Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2009 Aug; 74(165):43753-4236. PubMed ID: 19827228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2006 rates. Final rule.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2005 Aug; 70(155):47277-707. PubMed ID: 16097095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care financing policy for hospitalized rheumatology patients.
    Munoz E; Goldstein J; Benacquista T; Mulloy K; Wise L
    J Rheumatol; 1989 Jul; 16(7):885-9. PubMed ID: 2504916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What proposed DRG refinements mean for hospitals. Part III.
    Shoemaker P
    Health Syst Rev; 1994; 27(5):6, 8-11. PubMed ID: 10137370
    [No Abstract]   [Full Text] [Related]  

  • 15. Change in MS-DRG assignment and hospital reimbursement as a result of Centers for Medicare & Medicaid changes in payment for hospital-acquired conditions: is it coding or quality?
    McNutt R; Johnson TJ; Odwazny R; Remmich Z; Skarupski K; Meurer S; Hohmann S; Harting B
    Qual Manag Health Care; 2010; 19(1):17-24. PubMed ID: 20042930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and performance of different DRG classification systems for neonatal medicine.
    Muldoon JH
    Pediatrics; 1999 Jan; 103(1 Suppl E):302-18. PubMed ID: 9917473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgonomics as a health care financing policy for hospitalized surgical patients.
    Muñoz E; Goldstein J; Benacquista T; Mulloy K; Wise L
    Surg Gynecol Obstet; 1989 May; 168(5):421-5. PubMed ID: 2496483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2005. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Nov; 69(219):66235-915. PubMed ID: 15551493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Did the Medicare inpatient rehabilitation facility prospective payment system result in changes in relative patient severity and relative resource use?
    Paddock SM; Escarce JJ; Hayden O; Buntin MB
    Med Care; 2007 Feb; 45(2):123-30. PubMed ID: 17224774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.